Tacrolimus pharmacokinetics is associated with gut microbiota diversity in kidney transplant patients: results from a pilot cross‐sectional study

AL Degraeve, LB Bindels, V Haufroid… - Clinical …, 2024 - Wiley Online Library
Clinical use of tacrolimus (TAC), an essential immunosuppressant following transplantation,
is complexified by its high pharmacokinetic (PK) variability. The gut microbiota gains …

Tacrolimus pharmacokinetics is associated with gut microbiota diversity in kidney transplant patients: results from a pilot cross-sectional study.

AL Degraeve, LB Bindels, V Haufroid… - Clinical …, 2023 - europepmc.org
Clinical use of tacrolimus, an essential immunosuppressant following transplantation, is
complexified by its high pharmacokinetic variability. The gut microbiota gains growing …

[PDF][PDF] Tacrolimus pharmacokinetics is associated with gut microbiota diversity in kidney transplant patients: results from a pilot cross-sectional study.

P Joseph, DC Eddour - dial.uclouvain.be
Clinical use of tacrolimus, an essential immunosuppressant following transplantation, is
complexified by its high pharmacokinetic variability. The gut microbiota gains growing …

Tacrolimus Pharmacokinetics is Associated with Gut Microbiota Diversity in Kidney Transplant Patients: Results from a Pilot Cross-Sectional Study

AL Degraeve, LB Bindels, V Haufroid… - Clinical …, 2024 - pubmed.ncbi.nlm.nih.gov
Clinical use of tacrolimus (TAC), an essential immunosuppressant following transplantation,
is complexified by its high pharmacokinetic (PK) variability. The gut microbiota gains …

Tacrolimus pharmacokinetics is associated with gut microbiota diversity in kidney transplant patients: results from a pilot cross‐sectional study

A Degraeve, LB Bindels, V Haufroid… - Clinical …, 2023 - dial.uclouvain.be
Clinical use of tacrolimus, an essential immunosuppressant following transplantation, is
complexified by its high pharmacokinetic variability. The gut microbiota gains growing …